Online citations, reference lists, and bibliographies.
← Back to Search

The Present And Future Of Biomarkers In Prostate Cancer: Proteomics, Genomics, And Immunology Advancements

Pierre-Olivier Gaudreau, John Stagg, Denis Soulières, Fred Saad

Save to my Library
Download PDF
Analyze on Scholarcy
Share
Prostate cancer (PC) is the second most common form of cancer in men worldwide. Biomarkers have emerged as essential tools for treatment and assessment since the variability of disease behavior, the cost and diversity of treatments, and the related impairment of quality of life have given rise to a need for a personalized approach. High-throughput technology platforms in proteomics and genomics have accelerated the development of biomarkers. Furthermore, recent successes of several new agents in PC, including immunotherapy, have stimulated the search for predictors of response and resistance and have improved the understanding of the biological mechanisms at work. This review provides an overview of currently established biomarkers in PC, as well as a selection of the most promising biomarkers within these particular fields of development.